USA

Osseon® Therapeutics, Inc. has named Mr. Ron Clough as Chief Operating Officer. Mr. Clough has extensive experience with several companies that develop and market medical devices for the treatment of spinal disease and deformities…

IRIDEX Appoints Chairman William M. Moore as Interim President & CEO (via PR Newswire) MOUNTAIN VIEW, Calif., Aug. 28, 2012 … continue reading “New Interim President & CEO For Iridex”

Happtique, a mobile health application store and total app management solution, today announced the commencement of its pilot program of mRx, Happtique’s patent-pending solution that enables physicians and other health practitioners to electronically prescribe medical, health, and fitness apps to their patients.

Market intelligence company Millennium Research Group, reckons the U.S. Transcatheter Embolisation and Occlusion device market will grow at an average annual rate of just over nine percent through 2016, driven by an aging population and a trend away from traditional surgical procedures and toward minimally invasive procedures, with particular growth in aneurysm treatment.

Californian radiotherapy company Varian Medical Systems’ President and CEO Timothy Guertin has declared his intention to retire from the role after 35 years with the company.

Olive Medical Corporation, the self-styled low cost leader in 1080p HD surgical camera systems, has announced a contract with ROi (Resource Optimization & Innovation) in a move which the company says will help users deliver clinical excellence in the most cost-efficient manner.

EquinoxO2 Medical, developer of negative pressure wound therapy foam dressings and pump systems, has announced introduction and distribution of its HALO XP npwt pump system.

The US FDA is proposing to establish a system which would require the label of most medical devices and device packages to include a unique device identifier in an endeavour to identify potential problems earlier and better isolate affected populations.

Consumers Union is a powerful patient rights advocacy group in USA, and as such it’s perhaps not surprising to see it welcoming the Unique Device Identifier proposals from FDA… and asking why it’s taken so long.

It’s all a bit weird. Companies issue press releases containing information about their rosy prospects all the time, but they don’t often charge you for the privilege of reading them. Tissue Regeneration Technologies obviously has other ideas.

Richard Smith says it’s time to open up the finances of medical journals so we can see whether lucrative reprint business is risking clouding judgement. A bit more transparency about publications’ sources of income would perhaps provide comfort.

Precision Spine, Inc. has announced its purchase of Spinal USA, LLC and Precision Medical of Mississippi, LLC , privately held medical device companies headquartered in Pearl, MS, in a transaction valued at approximately $72 million.

The House of Representatives has voted 270-146 in favour of progressing the repeal act, but the game’s far from over as the bill may be squashed by a stubborn White House.

The harbingers of doom would have it that the medtech sales tax bit of Obamacare would reduce investment in innovation and in so doing kill people by not offering them lifesaving technologies that haven’t yet been invented. Mad argument maybe, but the real point is how well medtech industry has campaigned against the tax.

Things are coming to a head over the US medtech sales tax levy this week as a new act designed to repeal the original legislation, has found its way through the Committee on Ways and Means in the U.S. House of Representatives, with support from both parties.

InVivo Therapeutics Holdings Corp., has announced that former Stryker Spine, Inc. executive Robert Housler Jr., will be joining the company as the Vice President of Business Development.